Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: A preliminary report
Resumen: Introduction: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients.
Methods: In total, 13 serum samples from 13 HCC patients were screened using Fas2-ELISA.
Results: Fas2-ELISA demonstrated negative results in all HCC patients included in this study.
Conclusions: The pre-existence of F. hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies.

Idioma: Inglés
DOI: 10.1590/0037-8682-0180-2017
Año: 2018
Publicado en: Revista da Sociedade Brasileira de Medicina Tropical 51, 2 (2018), 231-233
ISSN: 0037-8682

Factor impacto JCR: 1.498 (2018)
Categ. JCR: TROPICAL MEDICINE rank: 13 / 21 = 0.619 (2018) - Q3 - T2
Categ. JCR: PARASITOLOGY rank: 22 / 36 = 0.611 (2018) - Q3 - T2

Factor impacto SCIMAGO: 0.701 - Infectious Diseases (Q3) - Parasitology (Q3) - Microbiology (medical) (Q3)

Tipo y forma: Article (Published version)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2020-01-13-14:54:43)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2018-06-19, last modified 2020-01-13


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)